Stalevo for Parkinson's
August 2003
See FDA information concerning a possible increased cardiovascular risk with Stalevo
Novartis is now marketing Stalevo for Parkinson's.
It contains both standard-release carbidopa/levodopa (Sinemet, etc)...PLUS entacapone (Comtan).
It's for patients who already take these drugs separately... or for patients who have "wearing-off" on levodopa. Adding entacapone boosts the efficacy of levodopa and helps it last longer.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote